ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,499, issued on Feb. 24, was assigned to Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Ariz.) and Universita degli Studi di Padova (Padua, Italy).

"Uses of compounds having anti-HSV-1 activity" was invented by Laurence Hurley (Tucson, Ariz.), Sara Richter (Padua, Italy) and Paola Solda (Padua, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides methods of treating, suppressing, inhibiting, reducing an incidence, reducing the pathogenesis of, ameliorating the symptoms of, or ameliorating the secondary symptoms of a primary or recurring Herpes Simplex Virus (HSV) infection, or prolonging the latency t...